Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.

Asia-Pacific journal of clinical oncology - 1 Oct 2022

Ip Emilia, Young Alison Luk, Scheinberg Tahlia, Harrison Michelle, Beale Philip, Goodwin Annabel

Abstract excerpt

INTRODUCTION: Mainstream genetic testing refers to genetic testing arranged by a patient's treating specialist. The aim of this study was to retrospectively review a Sydney-based ovarian cancer mainstream genetic testing program. METHODS: A Cancer Genetics Service (CGS)-supported mainstream genetic testing program was commenced in 2015. The CGS provided training, paperwork and ongoing and adaptable advice...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 35098668
DOI: 10.1111/ajco.13741

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.PMID 35098668Read ↗

An Australian mainstream genetic testing program: Clinicians views about current and future practicesSemantic proximity Read ↗

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingSemantic proximity Read ↗

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspectiveSemantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.Semantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsSemantic proximity Read ↗

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinicsSemantic proximity Read ↗

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read ↗

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing processSemantic proximity Read ↗

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancerSemantic proximity Read ↗

Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Semantic proximity Read ↗

Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing.Semantic proximity Read ↗

The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.